NOVEL ANTIBODY DRUG PRODUCTS

被引:2
作者
DIPIRO, JT
HAMILTON, RG
WEI, JP
机构
[1] UNIV GEORGIA,COLL PHARM,AUGUSTA,GA
[2] MED COLL GEORGIA,DEPT SURG,AUGUSTA,GA 30912
[3] JOHNS HOPKINS UNIV,SCH MED,CTR ASTHMA & ALLERGY,BALTIMORE,MD 21205
关键词
D O I
10.1016/S0002-9610(05)80653-1
中图分类号
R61 [外科手术学];
学科分类号
摘要
Recent developments in protein and genetic engineering methods have allowed the production of antibody-derived molecules that have important potential as therapeutic agents. Although monoclonal antibodies of murine origin have been used for therapeutic purposes, limitations due to anti-antibody responses and suboptimal effectiveness for some indications, such as tumor cell killing, have led to the development of human monoclonal antibodies, chimeric and complementarity determining-region grafted antibodies, immunotoxins, and other engineered products. These novel antibodies are being tested for the treatment and prevention of infectious diseases and for the diagnosis and treatment of cancers, as well as for indications considered nontraditional for antibodies (e.g., as antithrombotics or inhibitors of neutrophil adherence). The availability of antibody drug products raises a number of issues for clinicians. Among these are new patterns of adverse effects, immunogenicity (development of anti-antibody response), important questions regarding administration and dosage, and substantial cost implications.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 52 条
[1]  
BAUMGARTNER JD, 1985, LANCET, V2, P59
[2]   IMPACT OF RADIOLABELED ANTIBODY IMAGING ON MANAGEMENT OF COLON CANCER [J].
BEATTY, JD ;
HYAMS, DM ;
MORTON, BA ;
BEATTY, BG ;
WILLIAMS, LE ;
YAMAUCHI, D ;
MERCHANT, B ;
PAXTON, RJ ;
SHIVELY, JE .
AMERICAN JOURNAL OF SURGERY, 1989, 157 (01) :13-19
[3]  
BORREBAECK C, 1992, ANTIBODY ENG PRACTIC
[4]   GENERATION OF ANTIBODY-ACTIVITY FROM IMMUNOGLOBULIN POLYPEPTIDE-CHAINS PRODUCED IN ESCHERICHIA-COLI [J].
CABILLY, S ;
RIGGS, AD ;
PANDE, H ;
SHIVELY, JE ;
HOLMES, WE ;
REY, M ;
PERRY, LJ ;
WETZEL, R ;
HEYNEKER, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (11) :3273-3277
[5]   TREATMENT OF GRAM-NEGATIVE SEPTIC SHOCK WITH HUMAN-IGG ANTIBODY TO ESCHERICHIA-COLI J5 - A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED TRIAL [J].
CALANDRA, T ;
GLAUSER, MP ;
SCHELLEKENS, J ;
VERHOEF, J .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (02) :312-319
[6]   GANGLIOSIDE GD2 SPECIFIC MONOCLONAL ANTIBODY-3F8 - A PHASE-I STUDY IN PATIENTS WITH NEUROBLASTOMA AND MALIGNANT-MELANOMA [J].
CHEUNG, NKV ;
LAZARUS, H ;
MIRALDI, FD ;
ABRAMOWSKY, CR ;
KALLICK, S ;
SAARINEN, UM ;
SPITZER, T ;
STRANDJORD, SE ;
COCCIA, PF ;
BERGER, NA .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (09) :1430-1440
[7]  
COHEN AM, 1991, ARCH SURG-CHICAGO, V126, P349
[8]   INHIBITION OF HUMAN-PLATELET FUNCTION INVIVO WITH A MONOCLONAL-ANTIBODY - WITH OBSERVATIONS ON THE NEWLY DEAD AS EXPERIMENTAL SUBJECTS [J].
COLLER, BS ;
SCUDDER, LE ;
BERGER, HJ ;
IULIUCCI, JD .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (08) :635-638
[9]   MONOCLONAL-ANTIBODIES FOR TREATING CANCER [J].
DILLMAN, RO .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (07) :592-603
[10]  
DOERR RJ, 1990, ARCH SURG-CHICAGO, V125, P1601